BR112020003349A2 - composições e métodos para modular o crescimento capilar - Google Patents
composições e métodos para modular o crescimento capilar Download PDFInfo
- Publication number
- BR112020003349A2 BR112020003349A2 BR112020003349-9A BR112020003349A BR112020003349A2 BR 112020003349 A2 BR112020003349 A2 BR 112020003349A2 BR 112020003349 A BR112020003349 A BR 112020003349A BR 112020003349 A2 BR112020003349 A2 BR 112020003349A2
- Authority
- BR
- Brazil
- Prior art keywords
- acid
- electron transport
- transport chain
- inhibitor
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pain & Pain Management (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762566031P | 2017-09-29 | 2017-09-29 | |
| US62/566,031 | 2017-09-29 | ||
| PCT/US2018/053351 WO2019067860A1 (en) | 2017-09-29 | 2018-09-28 | COMPOSITIONS AND METHODS FOR MODULATION OF HAIR GROWTH |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112020003349A2 true BR112020003349A2 (pt) | 2020-08-18 |
Family
ID=65903207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112020003349-9A BR112020003349A2 (pt) | 2017-09-29 | 2018-09-28 | composições e métodos para modular o crescimento capilar |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20200253917A1 (enExample) |
| EP (1) | EP3687528A4 (enExample) |
| JP (1) | JP2020536048A (enExample) |
| KR (1) | KR20200062242A (enExample) |
| CN (1) | CN111295188A (enExample) |
| AU (1) | AU2018339064A1 (enExample) |
| BR (1) | BR112020003349A2 (enExample) |
| CA (1) | CA3077359A1 (enExample) |
| CL (1) | CL2020000676A1 (enExample) |
| EA (1) | EA202090855A1 (enExample) |
| IL (1) | IL272827A (enExample) |
| MX (1) | MX2020002389A (enExample) |
| PE (1) | PE20210464A1 (enExample) |
| PH (1) | PH12020500300A1 (enExample) |
| SG (2) | SG10202109849SA (enExample) |
| WO (1) | WO2019067860A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019015552A2 (pt) | 2017-02-24 | 2020-03-17 | The Regents Of The University Of California | Composições e métodos para promover crescimento capilar com os inibidores de mpc1 |
| MX2019015475A (es) | 2017-06-30 | 2020-02-19 | Univ California | Composiciones y metodos para modular el crecimiento del cabello. |
| KR102561912B1 (ko) * | 2021-04-09 | 2023-07-31 | 차의과학대학교 산학협력단 | 세팔로틴 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 포함하는 탈모방지 또는 발모촉진용 조성물 |
| CN113694063A (zh) * | 2021-08-31 | 2021-11-26 | 佛山市第一人民医院（中山大学附属佛山医院） | 一种组合物及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9014221D0 (en) * | 1990-06-26 | 1990-08-15 | Janssen Pharmaceutica Nv | Method of treating alopecia |
| AU3982601A (en) * | 2000-02-23 | 2001-09-03 | Orentreich Foundation For The | Methods and compositions for the treatment of alopecia and other disorders of the pilosebaceous apparatus |
| EP1796660B1 (en) * | 2004-09-17 | 2016-11-23 | BioMAS Ltd. | Use of ammonium trichloro(dioxyethylene-o,o')tellurate (as101) for the inhibition of interleukin-1beta-converting enzyme |
| AU2006339311A1 (en) * | 2005-06-07 | 2007-09-07 | Foamix Ltd. | Antibiotic kit and composition and uses thereof |
| US8343962B2 (en) * | 2006-03-06 | 2013-01-01 | Nuvo Research Inc. | Topical formulation |
| US9308181B2 (en) * | 2006-03-06 | 2016-04-12 | Nuvo Research Inc. | Topical formulations, systems and methods |
| US8563500B2 (en) * | 2007-09-05 | 2013-10-22 | Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts | Methods and compounds for treating diseases caused by reactive oxygen species |
| EP3178465A1 (en) * | 2010-12-06 | 2017-06-14 | Follica, Inc. | Methods for treating baldness and promoting hair growth |
| CN106880693A (zh) * | 2017-03-22 | 2017-06-23 | 广州国草夏方生物科技有限公司 | 一种治疗脂溢性脱发的生发液组合物及其制备方法 |
-
2018
- 2018-09-28 MX MX2020002389A patent/MX2020002389A/es unknown
- 2018-09-28 CA CA3077359A patent/CA3077359A1/en not_active Abandoned
- 2018-09-28 AU AU2018339064A patent/AU2018339064A1/en not_active Abandoned
- 2018-09-28 EP EP18862674.1A patent/EP3687528A4/en not_active Withdrawn
- 2018-09-28 EA EA202090855A patent/EA202090855A1/ru unknown
- 2018-09-28 JP JP2020512367A patent/JP2020536048A/ja not_active Withdrawn
- 2018-09-28 US US16/651,835 patent/US20200253917A1/en not_active Abandoned
- 2018-09-28 SG SG10202109849S patent/SG10202109849SA/en unknown
- 2018-09-28 SG SG11202001516QA patent/SG11202001516QA/en unknown
- 2018-09-28 BR BR112020003349-9A patent/BR112020003349A2/pt not_active Application Discontinuation
- 2018-09-28 CN CN201880063141.4A patent/CN111295188A/zh active Pending
- 2018-09-28 KR KR1020207011209A patent/KR20200062242A/ko not_active Ceased
- 2018-09-28 PE PE2020000361A patent/PE20210464A1/es unknown
- 2018-09-28 WO PCT/US2018/053351 patent/WO2019067860A1/en not_active Ceased
-
2020
- 2020-02-10 PH PH12020500300A patent/PH12020500300A1/en unknown
- 2020-02-20 IL IL272827A patent/IL272827A/en unknown
- 2020-03-16 CL CL2020000676A patent/CL2020000676A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN111295188A (zh) | 2020-06-16 |
| AU2018339064A1 (en) | 2020-02-27 |
| PE20210464A1 (es) | 2021-03-08 |
| EP3687528A4 (en) | 2021-07-21 |
| SG11202001516QA (en) | 2020-03-30 |
| IL272827A (en) | 2020-04-30 |
| SG10202109849SA (en) | 2021-10-28 |
| CL2020000676A1 (es) | 2020-09-25 |
| US20200253917A1 (en) | 2020-08-13 |
| EA202090855A1 (ru) | 2020-06-26 |
| JP2020536048A (ja) | 2020-12-10 |
| PH12020500300A1 (en) | 2020-11-09 |
| WO2019067860A1 (en) | 2019-04-04 |
| EP3687528A1 (en) | 2020-08-05 |
| KR20200062242A (ko) | 2020-06-03 |
| MX2020002389A (es) | 2020-10-01 |
| CA3077359A1 (en) | 2019-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ASTWOOD et al. | Action of certain sulfonamides and of thiourea upon the function of the thyroid gland of the rat | |
| BR112020003349A2 (pt) | composições e métodos para modular o crescimento capilar | |
| JP6796097B2 (ja) | 食欲不振制御化合物の組成物および使用方法 | |
| CN101426490B (zh) | 包含α-酮戊二酸/盐的组合物及其用于调节肌肉性能的用途 | |
| JP7120718B2 (ja) | 体重増加用化合物の長期使用のための組成物と方法 | |
| BR112015001989B1 (pt) | Uso de butilidenoftalida (bp) | |
| EP3366288B1 (en) | Lithium ascorbate exhibiting anti-stress, anxiolytic and anti-depression activity | |
| US20230040125A1 (en) | Targeting the intrinsic apoptotic machinery in glioblastoma | |
| BR112020009265A2 (pt) | medicamento e composição farmacêutica para a prevenção, alívio ou tratamento de crise de ausência ou epilepsia que apresenta crise de ausência, uso de um composto de carbamato ou um sal, solvato ou hidrato do mesmo, e, método para prevenir, aliviar ou tratar crise de ausência ou epilepsia que apresenta crise de ausência. | |
| BRPI0713094A2 (pt) | métodos de administração de droga | |
| HK40026046A (en) | Compositions and methods for modulating hair growth | |
| WO2025166338A2 (en) | Systemic mpc inhibition to reverse signs of aging | |
| KR20250044649A (ko) | X-ald 치료를 위한 갑상선 베타-작용제 투여 요법 | |
| WO2025188928A1 (en) | Administration of low-dose thiostrepton for treating cancer | |
| Li et al. | CFTR potentiation as a therapeutic strategy for pulmonary edema: a proof-of-concept study in pigs | |
| TWI672145B (zh) | 預防及／或治療代謝疾病的醫藥組合物及其用途 | |
| EP4580650A1 (en) | Thiostrepton dosing regimens | |
| WO2025117739A1 (en) | Compositions and methods for treating cancer | |
| USZ et al. | Buprenorphine via drinking water and combined oral-injection protocols for pain relief in mice | |
| BR102014006729A2 (pt) | métodos terapêuticos e composições para tratamento de diabetes utilizando compostos de diterpenoides | |
| JP2009265053A (ja) | 抗腫瘍作用の評価方法、およびこれを用いた抗腫瘍物質のスクリーニング方法 | |
| EA024747B1 (ru) | Средство для лечения кокцидиозов у птиц и животных |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |